Biotech

All Articles

Novartis pens $150M upfront bispecifics cope with Dren Bio

.Novartis has possessed some bad luck with bispecific antitoxins in the past, however determining du...

AstraZeneca plants an EGFR tree with Pinetree deal worth $45M

.Pinetree Therapies are going to help AstraZeneca plant some plants in its pipe with a brand-new tre...

GRO rounds up $60M set B to take gout therapy into facility

.GRO Biosciences has actually finished the week with an extra $60.3 thousand in the financial instit...

Chutes &amp Ladders-- Gilead's Merdad Parsey goes, Cassava drops CEO

.Welcome to this week's Chutes &amp Ladders, our roundup of significant management hirings, firings ...